Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1/2 pharmacokinetics and tolerability study of topical benvitimod cream in mild to moderate plaque psoriasis
ChiCTR-TRC-10000995Phase 2Completed
- Sponsor
- Peking University People's Hospital
- Start
- May 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of tapinarof in plaque psoriasis (3 arms), sponsored by Peking University People's Hospital. Primary endpoints: Adverse events, Psoriasis Area and Severity Index and 8 more. Started May 2010; status: completed.
02
Drugs
tapinarof
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on ChiCTR-TRC-10000995.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-10000995.